PDS Biotechnology Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| PDSB | HBP.TO | CGEN | CHRS | APLM | PYXS | |
|---|---|---|---|---|---|---|
| Market cap | 136.51M | 70.27M | 192.29M | 131.36M | 55.38M | 198.30M |
| P/E (TTM) | — | — | 5.3 | — | — | — |
| Forward P/E | -6.8 | -8.4 | -5.5 | -1.3 | -29.2 | -1.5 |
| Price/book | -20.3 | 4.8 | 2.2 | 2.2 | -12.8 | 9.2 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +46.23% | −54.68% | +23.78% | −42.95% | +71.38% | −58.91% |
| Today | −7.80% | 0.00% | +1.00% | +5.54% | −8.83% | +1.22% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All PDSB news ›Interleukin-33 Boosts Anti-PD-L1 Therapy in Liver Cancer
Wollongong-based online news outlet covering Australia and beyond. If you have anything newsworthy - a story, video or picture to share with us, please email us. This study demonstrates that cytokine IL-33 alleviates the immunosuppressive…
MD Anderson and Nature to host conference on next-generation cancer therapies
A three-day 2026 conference in Houston will examine emerging cancer therapeutics, targeted protein modulation, immunotherapies and artificial intelligence in drug development. The University of Texas MD Anderson Cancer Center and Springer…
PDS Biotechnology updates corporate presentation highlighting PDS0301 Phase 2 results, near-term data readouts
TradingView PDS Biotechnology updates corporate presentation highlighting PDS0301 Phase 2 results, near-term data readouts PDS Biotechnology updated its corporate presentation highlighting
PDS Biotechnology Corporation (PDSB) Discusses PDS-0301 Immunocytokine and Its Role in Treating Metastatic Colorectal Cancer - Slideshow
(NASDAQ:PDSB) 2026-10-17 Seeking Alpha The following slide deck was published by PDS Biotechnology Corporation in conjunction with this event.
Victor Moreno: Tumor Growth vs Antitumor Immunity, A New Strategy to Fight MSS Colorectal Cancer
Victor Moreno, Director of Clinical Research at START Madrid FJD, shared on LinkedIn: “Can the same target both promote and suppress cancer? And more intriguing, can this explain why some patients present ‘hyperprogression’ to…
Vividion Therapeutics Expands Clinical Development of WRN Inhibitor VVD-214 with Phase II Combination Study in First-Line Patients with Advanced Colorectal Cancer
The securities referred to herein will not be registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or any U.S. State security laws and may not be offered or sold in the United States absent registration…
PDSB Jumps As PDS Biotechnology’s Phase 2 Data Impress And Nant Deal Reshapes Outlook
www.timothysykes.com PDSB Jumps As PDS Biotechnology’s Phase 2 Data Impress And Nant Deal Reshapes Outlook PDS Biotechnology Corporation stocks have been trading up by 30.39 percent amid heightened optimism over i
9 Hepatobiliary Cancer Trials to Watch at ESMO 2026
This overview highlights 9 HCC and biliary tract cancer trials to watch at ESMO 2026. Abstract: LBA48 Presenter: Masatoshi Kudo (Osaka, Japan) Trial Type: Phase III Session: Proffered Paper session At ESMO 2026, EMERALD-3 will report liver…
Silencing PD-L1 Reveals a Hidden Phosphatase Axis That May Drive Gastric Cancer Survival
New research shows that silencing the PD-L1 gene in gastric cancer cells reshapes the expression of MAPK-regulating DUSP phosphatases, revealing a signaling axis with potential diagnostic and therapeutic value. Subject of Research: PD-L1…
FDA Approves Atezolizumab/Chemo for Stage III dMMR Colon Cancer
The FDA approved adjuvant atezolizumab with chemotherapy for patients with resected stage III dMMR colon cancer based on results from the phase 3 ATOMIC trial. CancerNetwork® previously reported that the FDA granted priority review to the…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- bayer.com1
- timothysykes.com1
- tradingview.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.